Interferon alpha-2a biosimilar (Biopartners GmbH)

干扰素α-2a生物类似药 (Biopartners GmbH)

Report date: 2022/01/24 13:25:42

Base Information

Drug NameInterferon alpha-2a biosimilar (Biopartners GmbH)

Drug Alias NameAlpheon干扰素α-2a生物仿制药 (Biopartners GmbH)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (NDA/BLA)

Highest Status in ChinaN/A

Originator CompaniesBiopartners Gmbh

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiopartners Gmbh

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeL03AB04